These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3056203)

  • 21. beta-lactam antibiotics in the treatment of neuroborreliosis in children: preliminary results.
    Millner MM; Thalhammer GH; Dittrich P; Spork KD; Brunner M; Georgopoulos A
    Infection; 1996; 24(2):174-7. PubMed ID: 8740117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lyme borreliosis: presentation and therapy.
    Goldings AS
    Neurology; 1991 Mar; 41(3):463. PubMed ID: 2053959
    [No Abstract]   [Full Text] [Related]  

  • 23. Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents--possible implications for new therapeutic approaches to Lyme disease.
    Hunfeld KP; Kraiczy P; Kekoukh E; Schäfer V; Brade V
    Int J Med Microbiol; 2002 Jun; 291 Suppl 33():125-37. PubMed ID: 12141737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans.
    Weber K; Preac-Mursic V; Neubert U; Thurmayr R; Herzer P; Wilske B; Schierz G; Marget W
    Ann N Y Acad Sci; 1988; 539():324-45. PubMed ID: 3056202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guideline 'Lyme borreliosis'].
    Speelman P; de Jongh BM; Wolfs TF; Wittenberg J;
    Ned Tijdschr Geneeskd; 2004 Apr; 148(14):659-63. PubMed ID: 15106316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis.
    Ogrinc K; Logar M; Lotric-Furlan S; Cerar D; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2006 Nov; 118(21-22):696-701. PubMed ID: 17160610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis.
    Pfister HW; Preac-Mursic V; Wilske B; Schielke E; Sörgel F; Einhäupl KM
    J Infect Dis; 1991 Feb; 163(2):311-8. PubMed ID: 1988514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of treatment options for lyme borreliosis.
    Taylor RS; Simpson IN
    J Chemother; 2005 Sep; 17 Suppl 2():3-16. PubMed ID: 16315580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pseudotumor cerebri caused by Lyme borreliosis].
    Ellermann A; Hjelt K
    Ugeskr Laeger; 1995 Feb; 157(7):901. PubMed ID: 7701654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation techniques for spirochetes and their sensitivity to antibiotics in vitro and in vivo.
    Johnson RC
    Rev Infect Dis; 1989; 11 Suppl 6():S1505-10. PubMed ID: 2682963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Stage-oriented treatment of Lyme borreliosis].
    Fingerle V; Wilske B
    MMW Fortschr Med; 2006 Jun; 148(25):39-41. PubMed ID: 16859159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lyme disease in Japan. Analysis of Borrelia species using rRNA gene restriction fragment length polymorphism.
    Hashimoto Y; Kawagishi N; Sakai H; Takahashi H; Matsuo S; Nakao M; Miyamoto K; Iizuka H
    Dermatology; 1995; 191(3):193-8. PubMed ID: 8534936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaphylactoid reaction caused by sodium ceftriaxone in two horses experimentally infected by Borrelia burgdorferi.
    Basile RC; Rivera GG; Del Rio LA; de Bonis TC; do Amaral GP; Giangrecco E; Ferraz G; Yoshinari NH; Canola PA; Queiroz Neto A
    BMC Vet Res; 2015 Aug; 11():197. PubMed ID: 26265349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials.
    Delong AK; Blossom B; Maloney EL; Phillips SE
    Contemp Clin Trials; 2012 Nov; 33(6):1132-42. PubMed ID: 22922244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.
    Dattwyler RJ; Luft BJ; Kunkel MJ; Finkel MF; Wormser GP; Rush TJ; Grunwaldt E; Agger WA; Franklin M; Oswald D; Cockey L; Maladorno D
    N Engl J Med; 1997 Jul; 337(5):289-94. PubMed ID: 9233865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective study.
    Müllegger RR; Millner MM; Stanek G; Spork KD
    Infection; 1991; 19(4):279-83. PubMed ID: 1917046
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Koetsveld J; Draga ROP; Wagemakers A; Manger A; Oei A; Visser CE; Hovius JW
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi.
    Ates L; Hanssen-Hübner C; Norris DE; Richter D; Kraiczy P; Hunfeld KP
    Ticks Tick Borne Dis; 2010 Mar; 1(1):30-4. PubMed ID: 21771509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular disease in Caribbean patients with serologic evidence of Lyme borreliosis.
    Winward KE; Smith JL
    J Clin Neuroophthalmol; 1989 Jun; 9(2):65-70. PubMed ID: 2526160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin.
    Brouqui P; Badiaga S; Raoult D
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1552-4. PubMed ID: 8726038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.